Breakdown | Mar 2025 | Mar 2024 | Mar 2023 | Mar 2022 | Mar 2021 |
---|---|---|---|---|---|
Income Statement | |||||
Total Revenue | 1.93B | 1.91B | 1.58B | 1.32B | 1.28B |
Gross Profit | 1.93B | 268.70M | 229.00M | 178.80M | 189.90M |
EBITDA | 26.20M | 290.90M | 261.70M | 183.60M | 205.10M |
Net Income | -185.70M | 139.60M | 154.40M | 90.00M | 121.70M |
Balance Sheet | |||||
Total Assets | 1.83B | 2.11B | 2.07B | 1.76B | 1.49B |
Cash, Cash Equivalents and Short-Term Investments | 290.60M | 231.00M | 156.90M | 248.70M | 191.00M |
Total Debt | 428.90M | 391.80M | 368.90M | 22.10M | 26.70M |
Total Liabilities | 1.20B | 1.18B | 1.10B | 713.30M | 596.90M |
Stockholders Equity | 626.50M | 926.10M | 968.30M | 1.04B | 889.40M |
Cash Flow | |||||
Free Cash Flow | 112.50M | 146.80M | 97.00M | 104.40M | 102.10M |
Operating Cash Flow | 221.30M | 243.10M | 206.00M | 188.70M | 181.60M |
Investing Cash Flow | 400.00K | -99.10M | -464.40M | -81.60M | -53.20M |
Financing Cash Flow | -158.40M | -63.20M | 159.70M | -47.30M | -55.60M |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
---|---|---|---|---|---|---|---|
76 Outperform | £701.49M | 34.70 | 14.40% | 99.55% | 13.49% | 47.00% | |
75 Outperform | £1.46B | 37.50 | 11.62% | 143.65% | 8.00% | 674.47% | |
72 Outperform | £138.98M | 32.16 | 3.87% | 96.44% | 14.30% | -25.58% | |
72 Outperform | £628.22M | 123.90 | 4.18% | 89.40% | 14.69% | ― | |
67 Neutral | £2.85B | 10.57 | 4.69% | 213.48% | 2.73% | -20.56% | |
63 Neutral | £2.70B | 17.97 | -23.92% | 177.07% | 1.02% | -240.44% | |
― | $72.79B | 30.80 | 17.85% | 0.08% | ― | ― |